Leading the charge to help educate and find solutions to the antimicrobial resistance crisis is Robin Patel, M.D., as she recently served on a congressional briefing panel.
Jane Hermansen, Manager, Outreach and Network Development, is featured on the cover of October’s MedicalLab Management where she takes a good look at lessons to be learned from Theranos.
The purpose of the panel was to provide insight into how some health care systems are paving the way for value-based care.
Matthew Binnicker, Ph.D., Director of the Clinical Virology Laboratory in the Division of Clinical Microbiology at Mayo Clinic, recently spoke with Consultant360 regarding testing for viral gastroenteritis.
Elitza Theel, Ph.D., Director of the Infectious Diseases Serology Laboratory, discusses eastern equine encephalitis virus, which is spread via mosquito bite.
Mayo Clinic Laboratories is thrilled to introduce “Lab Medicine Rounds.” This curated podcast for physicians, laboratory professionals, and students features trending topics from Mayo Clinic Laboratories subject-matter experts.
Dr. Pandey is a nuclear radiology researcher working with a team to develop a new radioactive tracer to detect prostate cancer.
Traditionally, Mayo Clinic’s Simulation Center is used for surgical procedures and teaching students how to run a code. Mayo Clinic pathology consultant Karen Fritchie, M.D., recently developed a new and innovative way to use the center.
Mayo Clinic startup company Vineti developed first-of-its-kind software package tracking for cell therapies. Vineti’s groundbreaking product captured a World Economic Forum Technology Pioneer Award in the field of health.
R. Ross Reichard, M.D., DLMP Vice Chair of Quality and Associate Chair of Practice, recently contributed to a College of American Pathologists (CAP) article in CAP Today. The article, “How the Laboratory Drives Patient Satisfaction,” explores the myriad ways laboratories can monitor and improve the patient experience.
Curtis Hanson, M.D., discusses the importance of detecting immunoglobulin heavy-chain variable region gene (IGHV) when acquiring prognostic and potentially therapeutic information in chronic lymphocytic leukemia (CLL) patients in CAP TODAY.
The current diagnostic tools in a pathologist’s arsenal sometimes cannot provide a clear distinction between primary mediastinal large B-cell lymphoma (one of the few lymphomas more common in younger women) and diffuse large B-cell lymphoma, the most common type of non-Hodgkin’s lymphoma overall.